AC
AMED

Allstate Corporation’s Amedisys AMED Stock Holding History

Allstate Corporation’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,688
Closed -$597K – 588
2021
Q4 		$597K Buy
3,688
+2,004
+119% +$322K 0.01% 647
2021
Q3 		$251K Sell
1,684
-57
-3% -$11.8K 0.01% 661
2021
Q2 		$426K Hold
1,741
– – 0.01% 563
2021
Q1 		$461K Hold
1,741
– – 0.01% 559
2020
Q4 		$511K Sell
1,741
-432
-20% -$111K 0.02% 506
2020
Q3 		$514K Sell
2,173
-357
-14% -$81.2K 0.02% 409
2020
Q2 		$502K Hold
2,530
– – 0.02% 436
2020
Q1 		$464K Buy
2,530
+925
+58% +$165K 0.02% 377
2019
Q4 		$268K Buy
+1,605
New +$239K ﹤0.01% 554

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Allstate Corporation's AMED Position: Q1 2022 in Review

Allstate Corporation sold out of Amedisys (AMED) in Q1 2022, closing a stake of 3,688 shares — an estimated $597K sold.

Allstate Corporation first reported a position in AMED in Q4 2019 and held it in 9 quarters. The position peaked at $597K in Q4 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • Allstate Corporation reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 3,688 Amedisys shares in Q1 2022, an estimated $597K.
  • Allstate Corporation first reported a position in Amedisys in Q4 2019 and held it in 9 quarters.
  • Allstate Corporation's Amedisys position peaked at $597K in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.